Human BCMA targeted T Cells Injection
HRAIN01-MM01
Phase 1 small_molecule active
Quick answer
Human BCMA targeted T Cells Injection for Multiple Myeloma is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active